KDventures AB ser. B (SE0002190926) — research page
SE · se-cm-kg/XSTO/SE0002190926 · as of 2026-11-06
Identity and listing
The issuer is KDventures AB ser. B, listed on Nasdaq Stockholm, with ticker SE0002190926, ISIN SE0002190926 and LEI 54930011ZA52NKO5W681. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | KDventures AB ser. B | source · 2026-11-06 |
| exchange | Nasdaq Stockholm | source · 2026-11-06 |
| ticker | SE0002190926 | source · 2026-11-06 |
| ISIN | SE0002190926 | source · 2026-11-06 |
| LEI | 54930011ZA52NKO5W681 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 50 filings in the twelve months to 2026-11-06, across 47 filing days. The median gap between filing days is 7.0 days. The latest filing is dated 2026-10-30 and is of type Inside information, 7 days before the record date. The exchange median is 7.0 days of latency and 9.5 days of cadence gap across 398 issuers, with a median of 30.0 filings. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 50 | 7 | 7 |
| exchange median: Nasdaq Stockholm (398 issuers) | 30 | 9.5 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-30 | Inside information | Inside information | KDventures portfolio company Umecrine Cognition reports results from Phase 1b/2a study of golexanolone in PBC - carrying value of holding to be adjusted to zero |
| 2026-10-21 | Investor News | Investor News | KDventures' portfolio company Modus Therapeutics' SEVUSMART study published in Nature Communications |
| 2026-10-21 | Investor News | Investor News | KDventures portfolio company Umecrine Cognition receives Notice of Allowance from USPTO for treatment of PBC symptoms with golexanolone |
| 2026-10-20 | Investor News | Investor News | KDventures portfolio company Umecrine Cognition's patient survey on severe fatigue in PBC selected as Poster of Distinction |
| 2026-10-15 | Changes board/management/auditors | Changes board/management/auditors | John Öhd focuses on Modus Therapeutics and continues as Senior Advisor to KDventures |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor and its location are not on the record. Auditor changes are not on the record, as the market's register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as the market's register has no lifecycle type map yet. The halt flag shows listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, with the chapter as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read, and the count is 0.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.
Sources
6 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/XSTO/SE0002190926 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://mcp.se-cm-kg.ai/record/XSTO/SE0002190926 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0002190926"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:d76768875b1d218e.